The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. Proton therapy is an advanced form of radiation therapy that uses high-energy proton beam rather than conventional radiotherapy to irradiate a tumor. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells.
The number of proton therapy centers is increasing in United States. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. The numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are huge. IBA dominates the proton therapy market. However, other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market.
The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers in United States is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth.
Key Topics Covered:
1. Executive Summary
2. United States Proton Therapy Market Analysis
3. United States - List of Proton Therapy Centers, Start of Treatment, Patient Treated
4. United States Proton Therapy - Company Analysis
5. United States - Number of Patients Treated at Proton Therapy Centers